Immune cells found near tumours boost breast cancer survival
10 June 2014Women with breast cancer are 10 per cent more likely to survive for five years or more if they have certain immune cells near their tumour, according to new research.
Women with breast cancer are 10 per cent more likely to survive for five years or more if they have certain immune cells near their tumour, according to new research.
Miniature scaffolds made from collagen 鈥 the 鈥榞lue鈥 that holds our bodies together 鈥 are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair the heart after a heart attack.
Deprivation could be responsible for around 450 deaths from breast cancer every year in England as women in lower income groups are likely to be diagnosed when the disease is more advanced, and treatment is less effective
Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman鈥檚 cancer is responding to treatment, according to a new study published in the New England Journal of Medicine.
Women with faults in BRCA genes are more likely to develop breast cancer if they are exposed to chest X-rays before they are 30, according to a study published in the BMJ online today.
Ahead of the first in a series of pub-based science talks, called 鈥淪ciBar鈥 this evening (16 August), Hayley Frend explains why fundamental knowledge about the mammary gland is still needed and how research in the field will impact on the treatment of breast cancer in the future.
Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
Researchers have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse.